Literature DB >> 7763206

Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease.

P Ryvlin1, E Broussolle, H Piollet, F Viallet, Y Khalfallah, G Chazot.   

Abstract

OBJECTIVE: To determine the changes in basal ganglia iron content associated with various stages of idiopathic Parkinson's disease.
DESIGN: Prospective magnetic resonance imaging study using a 2-T magnet.
SETTING: Ambulatory care referral center. PATIENTS AND PARTICIPANTS: Forty-five patients suffering from levodopa-responsive Parkinson's disease and 45 age-matched controls. MAIN OUTCOME MEASURES: The T2 relaxation time calculated in various regions of the basal ganglia, the duration of Parkinson's disease, and the age of subjects.
RESULTS: Patients with Parkinson's disease exhibited significantly decreased T2 relaxation time in the pars compacta of the substantia nigra compared with controls (P < .01), regardless of disease duration. Patients with a duration of illness above 10 years (n = 12) exhibited significantly increased T2 relaxation time in the anterior and posterior putamen (P < .005 and P < .01, respectively) and in the pallidum (P < .05) compared with age-matched controls. Putamental T2 relaxation time positively correlated with disease duration (P < .05).
CONCLUSION: These results suggest that more complex brain iron changes than those previously reported are associated with idiopathic Parkinson's disease, including increased nigral iron content and decreased putamenal and pallidal iron concentration in patients with a duration of illness above 10 years.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7763206     DOI: 10.1001/archneur.1995.00540300057013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  28 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

Review 3.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

4.  Magnetization transfer changes of grey and white matter in Parkinson's disease.

Authors:  N Tambasco; G P Pelliccioli; P Chiarini; G E Montanari; F Leone; M L Mancini; M Paciaroni; V Gallai
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

5.  Iron in neurodegenerative disorders.

Authors:  D. Berg; G. Becker; P. Riederer; O. Riess
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

Review 6.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

Review 7.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.

Authors:  Yi Wang; Pascal Spincemaille; Zhe Liu; Alexey Dimov; Kofi Deh; Jianqi Li; Yan Zhang; Yihao Yao; Kelly M Gillen; Alan H Wilman; Ajay Gupta; Apostolos John Tsiouris; Ilhami Kovanlikaya; Gloria Chia-Yi Chiang; Jonathan W Weinsaft; Lawrence Tanenbaum; Weiwei Chen; Wenzhen Zhu; Shixin Chang; Min Lou; Brian H Kopell; Michael G Kaplitt; David Devos; Toshinori Hirai; Xuemei Huang; Yukunori Korogi; Alexander Shtilbans; Geon-Ho Jahng; Daniel Pelletier; Susan A Gauthier; David Pitt; Ashley I Bush; Gary M Brittenham; Martin R Prince
Journal:  J Magn Reson Imaging       Date:  2017-03-10       Impact factor: 4.813

Review 8.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

9.  Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging.

Authors:  Wei Zhang; Sheng-Gan Sun; Yu-Hong Jiang; Xian Qiao; Xin Sun; Yan Wu
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

Review 10.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.